Project Details
| Status | Active |
|---|---|
| Effective start/end date | 6/12/23 → 6/12/26 |
Funding
- Nurix Therapeutics, Inc. (Prot #NX-5948-301)
NX-5948-301 - A Phase 1, Dose Escalation, and Cohort Expansion Study Evaluating NX-5948, a Bruton’s Tyrosine Kinase (BTK) Degrader, in Adults with Relapsed/Refractory B-cell Malignancies
- Dixit, Karan Singh (PD/PI)
Project: Research project